Multinational cooperation in trials and guidelines dealing with febrile neutropenia
- 23 October 2000
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (2) , 185-187
- https://doi.org/10.1016/s0924-8579(00)00240-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer ChemotherapyNew England Journal of Medicine, 1999
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Factors associated with bacteraemia in febrile, granulocytopenic cancer patientsEuropean Journal Of Cancer, 1994
- Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic PatientsClinical Infectious Diseases, 1992
- Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer PatientsThe Journal of Infectious Diseases, 1991
- From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverThe Journal of Infectious Diseases, 1990
- From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus PanelThe Journal of Infectious Diseases, 1990
- Empiric antifungal therapy in febrile granulocytopenic patientsThe American Journal of Medicine, 1989